Growth Metrics

Nano-X Imaging (NNOX) Current Deferred Revenue (2021 - 2025)

Nano-X Imaging filings provide 5 years of Current Deferred Revenue readings, the most recent being $551000.0 for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 293.57% to $551000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $551000.0, a 293.57% increase, with the full-year FY2025 number at $551000.0, up 236.72% from a year prior.
  • Current Deferred Revenue hit $551000.0 in Q4 2025 for Nano-X Imaging, up from $273000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $626.0 million in Q3 2022 to a low of -$107000.0 in Q1 2023.
  • Median Current Deferred Revenue over the past 5 years was $297000.0 (2024), compared with a mean of $37.1 million.
  • The widest YoY moves for Current Deferred Revenue: up 4228.57% in 2023, down 345.83% in 2023.
  • Nano-X Imaging's Current Deferred Revenue stood at $662000.0 in 2021, then fell by 12.39% to $580000.0 in 2022, then decreased by 6.38% to $543000.0 in 2023, then crashed by 74.22% to $140000.0 in 2024, then surged by 293.57% to $551000.0 in 2025.
  • The last three reported values for Current Deferred Revenue were $551000.0 (Q4 2025), $273000.0 (Q3 2025), and $224000.0 (Q2 2025) per Business Quant data.